Agios Pharmaceuticals, Inc. (AGIO)
31.81
-0.11
(-0.34%)
USD |
NASDAQ |
Oct 09, 16:00
31.81
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Cash from Operations (Quarterly) : -57.31M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -57.31M |
| March 31, 2026 | -118.92M |
| December 31, 2025 | -96.21M |
| September 30, 2025 | -88.15M |
| June 30, 2025 | -77.12M |
| March 31, 2025 | -111.49M |
| December 31, 2024 | -133.17M |
| September 30, 2024 | -84.22M |
| June 30, 2024 | -72.59M |
| March 31, 2024 | -99.87M |
| December 31, 2023 | -72.49M |
| September 30, 2023 | -61.64M |
| June 30, 2023 | -66.75M |
| March 31, 2023 | -95.18M |
| December 31, 2022 | -66.16M |
| September 30, 2022 | -71.35M |
| June 30, 2022 | -74.23M |
| March 31, 2022 | -97.74M |
| December 31, 2021 | -84.09M |
| September 30, 2021 | -85.18M |
| June 30, 2021 | -117.29M |
| March 31, 2021 | -120.75M |
| December 31, 2020 | -49.40M |
| September 30, 2020 | -68.21M |
| June 30, 2020 | -67.80M |
| Date | Value |
|---|---|
| March 31, 2020 | -105.36M |
| December 31, 2019 | -93.61M |
| September 30, 2019 | -85.59M |
| June 30, 2019 | -88.15M |
| March 31, 2019 | -103.27M |
| December 31, 2018 | -74.19M |
| September 30, 2018 | -63.84M |
| June 30, 2018 | -67.40M |
| March 31, 2018 | -99.00M |
| December 31, 2017 | -74.45M |
| September 30, 2017 | -77.72M |
| June 30, 2017 | -58.99M |
| March 31, 2017 | -74.07M |
| December 31, 2016 | -51.22M |
| September 30, 2016 | -49.03M |
| June 30, 2016 | 157.82M |
| March 31, 2016 | -19.01M |
| December 31, 2015 | -30.53M |
| September 30, 2015 | -24.82M |
| June 30, 2015 | 3.98M |
| March 31, 2015 | -25.58M |
| December 31, 2014 | -7.775M |
| September 30, 2014 | -23.47M |
| June 30, 2014 | -1.071M |
| March 31, 2014 | -27.04M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Biogen, Inc. | 448.90M |
| Insmed, Inc. | -88.83M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Regeneron Pharmaceuticals, Inc. | 813.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 40.21M |
| Cash from Financing (Quarterly) | 3.149M |
| Free Cash Flow | -365.25M |
| Free Cash Flow Per Share (Quarterly) | -0.9838 |
| Free Cash Flow to Equity (Quarterly) | -53.95M |
| Free Cash Flow to Firm (Quarterly) | -58.52M |
| Free Cash Flow Yield | -19.57% |